us stocks traded higher with the dow jones gaining around 100 points on thursday here are some big stocks recording gains in today’s session   shiftpixy inc shares surged 738 to 1948 after the company announced plans to spinoff shiftpixy labs and dividend its digital securities to shareholders   amylyx pharmaceuticals inc surged 64 to 2935 after the fda advisory committee voted that available evidence of effectiveness is sufficient to support approval of amx0035 for the treatment of als citigroup and svb leerink raised their price targets   asana inc shares gained 21 to 2303 after the company reported betterthanexpected results for its second quarter and issued a strong sales guidance rbc capital and citigroup raised their price targets on the stock   relay therapeutics inc surged 199 to 3040 relay therapeutics announced efficacy of rly4008 a highly selective fgfr2 inhibitor in patients with a fgfr2fusion or rearrangement fgfr inhibitornaïve cholangiocarcinoma refocus trial   lifestance health group inc gained 176 to 895 lifestance health named ken burdick as ceo and chairman   aerovironment inc gained 153 to 10220 after reporting upbeat quarterly sales   eve holding inc surged 148 to 707 united reported a 15 million investment in eve air mobility and a conditional purchase agreement for 200 fourseat electric aircraft plus 200 options   cazoo group ltd surged 147 to 070 the company announced it will wind down operations in mainland europe to focus on core uk market   rhythm pharmaceuticals inc gained 146 to 2390 rhythm pharmaceuticals announced new employment inducement grants goldman sachs maintained rhythm pharmaceuticals with a buy and raised the price target from 28 to 31   regeneron pharmaceuticals inc gained 141 to 68056 after the company announced that the primary endpoints were met in two pivotal trials investigating novel aflibercept 8 mg with 12 and 16week dosing regimens in patients with diabetic macular edema and wet agerelated macular degeneration   phreesia inc gained 136 to 2719 after the company reported betterthanexpected q2 sales results and raised the lowend of its fy23 sales guidance   intapp inc gained 124 to 1652 after the company reported betterthanexpected q4 results and issued guidance above estimates   albireo pharma inc surged 11 to 1850 guggenheim initiated coverage on albireo pharma with a buy rating and announced a price target of 55   lyft inc gained 105 to 1625 amid vague rumors from a questionable source mentioning the company   iveric bio inc rose 88 to 1624 stifel maintained iveric bio with a buy and raised the price target from 28 to 35   snap inc rose 73 to 1229 on continued strength after a recent internal memo obtained by the verge suggested the company is aiming to reach 6 billion in revenue and 450 million users by next year   gamestop corp rose 7 to 2572 after the company reported betterthanexpected earnings for its second quarter and also announced a partnership with cryptocurrency exchange ftx to bring more customers to the digital asset space   zillow group inc gained 69 to 3780 after jefferies maintained a buy rating on the stock and raised its price target from 48 to 50